MORE►
CPRIT
Composite photo; source: CNW Group/Perimeter Medical Imaging AI Inc./DI Studio]
In a ‘First,’ Perimeter’s Claire AI‑Enabled Imaging Device for Breast Cancer Surgery Gains FDA Approval
by Sandra Engelland | Mar 4, 2026
Designated by the FDA as a Breakthrough Device, Claire is designed to enhance surgeons' ability to detect difficult-to-see cancer during breast-conserving surgery and potentially reduce the need for re-operations.
by Sandra Engelland |
Jan 14, 2026
With more than two decades of experience in life sciences leadership, venture capital, and company building, Steven Weinstein brings a track record of guiding innovative healthcare organizations from early-stage development through commercialization, Carrollton-based Gradalis said.
MORE►
by Dallas Innovates | Staff Report |
Dec 5, 2025
The Cancer Prevention & Research Institute of Texas offers funding opportunities for promising cancer research, product development, and prevention programs. The state-funded initiative stands as the second-largest public backer of cancer research in the U.S. after the National Cancer Institute.
MORE►
by Glenn Hunter |
Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
Illustration: bsd555/iStock
CPRIT Awards $9.5M in Cancer Research Grants to SMU and Dallas’ Baylor Research Institute
by Lance Murray | Aug 17, 2023
The 29 new grants approved by CPRIT's Oversight Committee include the first CPRIT Scholar award to Southern Methodist University in Dallas and state funding for Dallas' Baylor Research Institute to join a major National Cancer Institute study.
MORE►
by Lance Murray |
Mar 13, 2023
“Our researchers continue to push the envelope on developing a better understanding of cancer and new ways to help cancer patients in Texas and beyond,” said Center Director Carlos L. Arteaga, M.D.
MORE►
by Dallas Innovates | Staff Report |
Feb 17, 2023
The Cancer Prevention and Research Institute of Texas approved over $90 million in new cancer research and prevention grants at its quarterly meeting near the Texas Capitol on Wednesday—and $20.6 million of that money is coming to North Texas to advance everything from breast cancer and lung cancer screening to "deep learning models" to facilitate T-cell receptor therapies.
MORE►
by Kevin Cummings |
Sep 6, 2022
The Cancer Prevention & Research Institute of Texas has provided more than $3.1 billion in funding toward the development of cancer-fighting therapeutics, devices, diagnostics, and tools since 2010. It's now issued a call for startups and early-stage companies to apply for product development research grants for the 2023 fiscal year.
“CPRIT’s mission is to invest in the research prowess of Texas institutions while expediting breakthroughs in cancer cures and prevention,” CEO Wayne Roberts said last May.
MORE►
OncoNano CEO Martin Driscoll [Photo: OncoNano]
OncoNano Caps $68.4M Series B Round With $18.4M Equity Investment From CPRIT for Cancer-Fighting Tech and Therapies
by David Seeley | Oct 25, 2021
The Cancer Prevention and Research Institute of Texas (CPRIT) will convert previous grant awards to an equity investment. OncoNano uses pH as a biomarker to detect metastatic cancer. The technology "lights up" a tumor in imaging during real-time surgery.
MORE►
by Quincy Preston |
Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
by Lance Murray |
Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE►
by Lance Murray |
Aug 27, 2019
Southlake-based biotech OncoNano received the largest grant in DFW with $15.4 million from the state agency that funds cancer research in Texas.
MORE►
Logo courtesy of bionorthTX; background: Svit Den/iStockphoto
Future of Health Care: Life Science Leaders Outline What Lies Ahead for Industry at iC3 Summit
by Nicholas Sakelaris | Oct 13, 2017
From the future of Cancer Prevention & Research Institute of Texas grants to patient records innovation, leaders discussed issues facing the industry.
MORE►
